Cargando…

Audiology findings in patients with teprotumumab associated otologic symptoms

PURPOSE: To report a case series of subjective and objective hearing function changes associated with teprotumumab treatment for thyroid eye disease. OBSERVATIONS: A 74-year-old female with a history of Graves' disease with thyroid eye disease was treated with teprotumumab. She had a history of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Caroline Y., Correa, Tatiana, Simmons, Brittany A., Hansen, Marlan R., Shriver, Erin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452766/ https://www.ncbi.nlm.nih.gov/pubmed/34585021 http://dx.doi.org/10.1016/j.ajoc.2021.101202

Ejemplares similares

Audiologic Demonstration of Ototoxicity From Teprotumumab Treatment in a Patient With Thyroid Eye Disease
por: Najjar, Wassim, et al.
Publicado: (2022)

The Effect of Teprotumumab on Eyelid Position in Patients with Thyroid Eye Disease
por: Simmons, Brittany A., et al.
Publicado: (2022)

Otologic and audiologic findings in 22q11.2 deletion syndrome
por: Verheij, E., et al.
Publicado: (2016)

Audiological and otologic manifestations of glutaric aciduria type I
por: Chen, Yen-Chi, et al.
Publicado: (2020)

Implementation of Wideband Acoustic Immittance in Clinical Practice: Relationships among Audiologic and Otologic Findings
por: Sanford, Chris A., et al.
Publicado: (2023)

Teprotumumab for Treatment of Pretibial Myxedema
por: Reyes, Michelangelo P, et al.
Publicado: (2023)

Relapsing polychondritis and otologic findings
por: Derin, Serhan, et al.
Publicado: (2014)

A case of pretibial myxedema treated with teprotumumab
por: Petit, Lauren, et al.
Publicado: (2021)

Teprotumumab in advanced reactivated thyroid eye disease
por: Cheng, Olivia T., et al.
Publicado: (2022)

Audiological findings in the Charcot-Marie-Tooth Disease
por: Fukushima, Erika, et al.
Publicado: (2015)

Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease
por: Hoang, Thanh Duc, et al.
Publicado: (2021)

Early experience with teprotumumab for chronic thyroid eye disease
por: Ozzello, Daniel J., et al.
Publicado: (2020)

Audiological findings in a case of cerebellar angioreticuloma
por: SERRA, A., et al.
Publicado: (2015)

Otologic and audiologic characteristics of type 2 diabetics in a tertiary health institution in Nigeria()
por: Adebola, Stephen Oluwatosin, et al.
Publicado: (2016)

A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease
por: Safo, Myra B., et al.
Publicado: (2021)

Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease
por: Varma, Aakaash, et al.
Publicado: (2020)

Audiological findings of a patient with H syndrome: case report
por: Hussein, Diala, et al.
Publicado: (2021)

Hearing Loss and Teprotumumab
por: Kossler, Andrea, et al.
Publicado: (2021)

Teprotumumab-associated chronic hearing loss screening and proposed treatments
por: Chow, Audrey, et al.
Publicado: (2022)

Effects of teprotumumab on patients with long-standing, active thyroid eye disease
por: Vinson, Kyle B., et al.
Publicado: (2022)

Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report
por: Lu, Tracy J., et al.
Publicado: (2023)

Retinal Surface Macrophage Changes in Thyroid Eye Disease before and after Treatment with Teprotumumab
por: Otero-Marquez, Oscar, et al.
Publicado: (2022)

Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study
por: Sears, Connie M., et al.
Publicado: (2021)

A Case of Unilateral Otologic Symptoms as Initial Manifestations of Granulomatosis With Polyangiitis
por: Batinović, Franko, et al.
Publicado: (2023)

Partial Recovery of Audiological, Vestibular, and Radiological Findings following Spontaneous Intralabyrinthine Haemorrhage
por: Pézier, Thomas, et al.
Publicado: (2013)

Operationalization of the Brief ICF Core Set for Hearing Loss: An ICF-Based e-Intake Tool in Clinical Otology and Audiology Practice
por: van Leeuwen, Lisette M., et al.
Publicado: (2020)

Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Post-COVID-19 Syndrome: Audiometric Findings in Patients with Audiological Symptoms
por: Ríos Coronado, Oscar O., et al.
Publicado: (2023)

Elasomeran/teprotumumab: Thyroid-eye disease flare, diarrhoea and muscle spasms: case report
Publicado: (2022)

AUDIOLOGY AND AUDIOLOGICAL MEDICINE
Publicado: (1982)

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
por: Bowens, Brendan K., et al.
Publicado: (2022)

Thyroid dermopathy responds to teprotumumab therapy
por: Crespo-Trevino, Ricaurte, et al.
Publicado: (2022)

Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy
por: Smith, Terry J.
Publicado: (2020)

Effect of teprotumumab on intraocular pressure in thyroid-associated ophthalmopathy
por: Adetunji, Modupe O., et al.
Publicado: (2022)

Indication criteria for cochlear implants and hearing aids: impact of audiological and non-audiological findings
por: Haumann, Sabine, et al.
Publicado: (2012)

Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Hearing Loss and Access to Audiology Services in Rural Victoria: Findings From the Crossroads Study
por: Glenister, Kristen M., et al.
Publicado: (2019)

Barriers to and enablers of the implementation of an ICF-based intake tool in clinical otology and audiology practice—A qualitative pre-implementation study
por: van Leeuwen, Lisette M., et al.
Publicado: (2018)

Teprotumumab for the treatment of mild compressive optic neuropathy in thyroid eye disease: A report of two cases
por: Chiou, Carolina A., et al.
Publicado: (2021)

Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series
por: Chu, Matthew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8qvs854h99c2r7ombeass7ba08